Keywords: bbg, new, cancer, drug, enters, trials, phase

BBG'S NEW CANCER DRUG ENTERS TRIALS

Article | 22 June 1992

Print This

A Phase I/II clinical trial of British Bio-technology Group's novel broad spectrum matrix metalloproteinase inhibitor, BB-94, has now begun ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in